145 related articles for article (PubMed ID: 24445061)
1. Home spirometry as early detector of azithromycin refractory bronchiolitis obliterans syndrome in lung transplant recipients.
de Wall C; Sabine D; Gregor W; Mark G; Axel H; Thomas F; Tobias W; Jens G
Respir Med; 2014 Feb; 108(2):405-12. PubMed ID: 24445061
[TBL] [Abstract][Full Text] [Related]
2. Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients.
Shitrit D; Bendayan D; Gidon S; Saute M; Bakal I; Kramer MR
J Heart Lung Transplant; 2005 Sep; 24(9):1440-3. PubMed ID: 16143268
[TBL] [Abstract][Full Text] [Related]
3. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
[TBL] [Abstract][Full Text] [Related]
4. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study.
Gerhardt SG; McDyer JF; Girgis RE; Conte JV; Yang SC; Orens JB
Am J Respir Crit Care Med; 2003 Jul; 168(1):121-5. PubMed ID: 12672648
[TBL] [Abstract][Full Text] [Related]
5. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome.
Yates B; Murphy DM; Forrest IA; Ward C; Rutherford RM; Fisher AJ; Lordan JL; Dark JH; Corris PA
Am J Respir Crit Care Med; 2005 Sep; 172(6):772-5. PubMed ID: 15976371
[TBL] [Abstract][Full Text] [Related]
6. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.
Jain R; Hachem RR; Morrell MR; Trulock EP; Chakinala MM; Yusen RD; Huang HJ; Mohanakumar T; Patterson GA; Walter MJ
J Heart Lung Transplant; 2010 May; 29(5):531-7. PubMed ID: 20133163
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis.
Kingah PL; Muma G; Soubani A
Clin Transplant; 2014 Aug; 28(8):906-10. PubMed ID: 24931185
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome.
Verleden GM; Vanaudenaerde BM; Dupont LJ; Van Raemdonck DE
Am J Respir Crit Care Med; 2006 Sep; 174(5):566-70. PubMed ID: 16741151
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients.
Dusmet M; Maurer J; Winton T; Kesten S
J Heart Lung Transplant; 1996 Sep; 15(9):948-54. PubMed ID: 8889991
[TBL] [Abstract][Full Text] [Related]
10. Long-term clarithromycin therapy in the management of lung transplant recipients.
Benden C; Boehler A
Transplantation; 2009 May; 87(10):1538-40. PubMed ID: 19461491
[TBL] [Abstract][Full Text] [Related]
11. Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer?
Vos R; Vanaudenaerde BM; Ottevaere A; Verleden SE; De Vleeschauwer SI; Willems-Widyastuti A; Wauters S; Van Raemdonck DE; Nawrot TS; Dupont LJ; Verleden GM
J Heart Lung Transplant; 2010 Dec; 29(12):1358-68. PubMed ID: 20619683
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of azithromycin in bronchiolitis obliterans syndrome.
Gan CT; Ward C; Meachery G; Lordan JL; Fisher AJ; Corris PA
BMJ Open Respir Res; 2019; 6(1):e000465. PubMed ID: 31673366
[TBL] [Abstract][Full Text] [Related]
13. Effect of maintenance azithromycin on established bronchiolitis obliterans syndrome in lung transplant patients.
Porhownik NR; Batobara W; Kepron W; Unruh HW; Bshouty Z
Can Respir J; 2008; 15(4):199-202. PubMed ID: 18551201
[TBL] [Abstract][Full Text] [Related]
14. Lung transplantation: the role of azithromycin in the management of patients with bronchiolitis obliterans syndrome.
Fietta AM; Meloni F
Curr Med Chem; 2008; 15(7):716-23. PubMed ID: 18336286
[TBL] [Abstract][Full Text] [Related]
15. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.
Vanaudenaerde BM; Meyts I; Vos R; Geudens N; De Wever W; Verbeken EK; Van Raemdonck DE; Dupont LJ; Verleden GM
Eur Respir J; 2008 Oct; 32(4):832-43. PubMed ID: 18827151
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.
Vos R; Vanaudenaerde BM; Verleden SE; Ruttens D; Vaneylen A; Van Raemdonck DE; Dupont LJ; Verleden GM
Transplantation; 2012 Jul; 94(2):101-9. PubMed ID: 22461039
[TBL] [Abstract][Full Text] [Related]
17. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.
Davis RD; Lau CL; Eubanks S; Messier RH; Hadjiliadis D; Steele MP; Palmer SM
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):533-42. PubMed ID: 12658195
[TBL] [Abstract][Full Text] [Related]
18. Effect of adherence to home spirometry on bronchiolitis obliterans and graft survival after lung transplantation.
Kugler C; Fuehner T; Dierich M; DeWall C; Haverich A; Simon A; Welte T; Gottlieb J
Transplantation; 2009 Jul; 88(1):129-34. PubMed ID: 19584692
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation.
Corris PA; Ryan VA; Small T; Lordan J; Fisher AJ; Meachery G; Johnson G; Ward C
Thorax; 2015 May; 70(5):442-50. PubMed ID: 25714615
[TBL] [Abstract][Full Text] [Related]
20. Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection.
Federica M; Nadia S; Monica M; Alessandro C; Tiberio O; Francesco B; Mario V; Maria FA
Clin Transplant; 2011; 25(4):E381-9. PubMed ID: 21418327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
